Around 25 percent of U.S. respondents in grades 8, 10, and 12 in 2024 stated that they used any illicit drug within their lifetime. This survey shows the lifetime prevalence of use of any illicit drug for grades 8, 10, and 12 combined from 1991 to 2024.
Identifies Tempe youth regarding substance misuse and other problematic youth behaviors, utilizing the Arizona Youth Survey that is administered by the Arizona Criminal Justice Commission, on behalf of the State of Arizona, biennially to Arizona 8th, 10th and 12th grade students. This alllows for data driven decision making to provide comprehensive youth substance use prevention educations to youth, parents, educators, and community stakeholders. This data also assist in creating goals and objectives to support Tempe youth along with securing grant funding from federal and state agencies. This page provides data for the Youth Drug Use and Misuse performance measure. The performance measure dashboard is available at 1.21 Youth Drug Use and MisuseAdditional InformationSource: Arizona Criminal Justice Commission Statistical Analysis CenterContact: Bernadette CogginsContact E-Mail: Bernadette_Coggins@tempe.govData Source Type: Excel; csvPreparation Method: Data extracted from Arizona Youth Survey, then manually compiled by outcomePublish Frequency: Every 2 years Publish Method: ManualData Dictionary (update pending)
From 2018 to 2019, around *** percent of Hispanic adolescents aged 12 to 17 years in the United States reported having a substance abuse disorder during the past year. This statistic illustrates the percentage of adolescents in the U.S. with substance abuse disorders from 2018 to 2019, by race and ethnicity.
Maintain the percentage of youth ages 12-17 exposed to a substance abuse prevention message at 86.6% every year through 2018.
https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
This report contains results from the latest survey of secondary school pupils in England in years 7 to 11 (mostly aged 11 to 15), focusing on smoking, drinking and drug use. It covers a range of topics including prevalence, habits, attitudes, and wellbeing. This survey is usually run every two years, however, due to the impact that the Covid pandemic had on school opening and attendance, it was not possible to run the survey as initially planned in 2020; instead it was delivered in the 2021 school year. In 2021 additional questions were also included relating to the impact of Covid. They covered how pupil's took part in school learning in the last school year (September 2020 to July 2021), and how often pupil's met other people outside of school and home. Results of analysis covering these questions have been presented within parts of the report and associated data tables. It includes this summary report showing key findings, excel tables with more detailed outcomes, technical appendices and a data quality statement. An anonymised record level file of the underlying data on which users can carry out their own analysis will be made available via the UK Data Service later in 2022 (see link below).
In 2020, the drug abuse arrest rate for persons under age 18 in Wyoming stood at ***, the most out of any state. The national average stood at *** in that same year. The arrest rate is defined as the number of arrests of persons under age 18 for every 100,000 persons aged 10 to 17.
https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
Contains a set of data tables for each part of the Smoking, Drinking and Drug Use among Young People in England, 2021 report
This short report uses data from the 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs), the 2010 Treatment Episode Data Set (TEDS), the 2010 National Survey of Substance Abuse Treatment Services (N-SSATS), and the 2011 Drug Abuse Warning Network (DAWN) to present facts about adolescent substance use, including information on the initiation of substance use, past year substance use, emergency department visits, and receipt of substance use treatment.
https://www.icpsr.umich.edu/web/ICPSR/studies/3404/termshttps://www.icpsr.umich.edu/web/ICPSR/studies/3404/terms
Drug Abuse Treatment Outcome Study - Adolescent (DATOS-A) was a multisite, prospective, community-based, longitudinal study of adolescents entering treatment. It was designed to evaluate the effectiveness of adolescent drug treatment by investigating the characteristics of the adolescent population, the structure and process of drug abuse treatment in adolescent programs, and the relationship of these factors with outcomes. Three major types or modalities of programs included in the study were chemical dependency or short-term inpatient (STI), therapeutic community or residential (RES), and outpatient drug-free (ODF). The adolescent battery of instruments included intake, intreatment, and follow-up questionnaires based largely on the DATOS adult study DRUG ABUSE TREATMENT OUTCOME STUDY (DATOS), 1991-1994: UNITED STATES instrument format, with considerable tailoring to the adolescent population. Clients entering treatment completed two comprehensive intake interviews (Intake 1 and Intake 2), approximately one week apart. This information is provided in Parts 1 and 2 of the data collection. These interviews were designed to obtain baseline data on drug use and other behaviors, such as illegal involvement, as well as information on background and demographic characteristics, education and training, mental health status, employment, income and expenditures, drug and alcohol dependence, health, religiosity and self-concept, and motivation and readiness for treatment. The one-, three-, and six-month intreatment interviews (Parts 3, 4, and 7) included items on treatment access, intreatment experience, and psychological functioning, as well as questions replicated from some of the domains in the Intake 1 and 2 questionnaires. The 12-month post-treatment follow-up interview (Part 5) included questions replicated from the previous interviews, and also included post-treatment status. Part 6 includes variables for time in treatment and interview availability indicators. The Measures Data (Part 8) were generated by using the Diagnostic and Statistical Manual of Mental Disorders (Rev. 3rd ed., DSM-III-R) (American Psychiatric Association, 1987). The variables in Part 8 give either the DSM-III-R level of dependence to a drug category or they describe whether the subject meets the DSM-III-R standard for a particular disorder. The 12-Month Follow-up Urine Result data (Part 9) provide the results from urine sample tests that were given to a sample of subjects at the time of the 12-Month Follow-up Interview. The urine test was used to ascertain the nature and extent of bias in the self-reports of the respondents. Urine specimens were tested for eight categories of drugs (amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine metabolite, methaqualone, opiates, and phencyclidine). The drugs covered in the study were alcohol, tobacco, marijuana (hashish, THC), cocaine (including crack), heroin, narcotics or opiates such as morphine, codeine, Demerol, Dilaudid, and Talwin, illegal methadone, sedatives and tranquilizers such as barbiturates and depressants, amphetamines or other stimulants such as speed or diet pills, methamphetamines, LSD, PCP, and other hallucinogens or psychedelics, and inhalants such as glue, gasoline, paint thinner, and aerosol sprays. The study also included drug of choice, frequency, and route of administration.
Database of the nation''s substance abuse and mental health research data providing public use data files, file documentation, and access to restricted-use data files to support a better understanding of this critical area of public health. The goal is to increase the use of the data to most accurately understand and assess substance abuse and mental health problems and the impact of related treatment systems. The data include the U.S. general and special populations, annual series, and designs that produce nationally representative estimates. Some of the data acquired and archived have never before been publicly distributed. Each collection includes survey instruments (when provided), a bibliography of related literature, and related Web site links. All data may be downloaded free of charge in SPSS, SAS, STATA, and ASCII formats and most studies are available for use with the online data analysis system. This system allows users to conduct analyses ranging from cross-tabulation to regression without downloading data or relying on other software. Another feature, Quick Tables, provides the ability to select variables from drop down menus to produce cross-tabulations and graphs that may be customized and cut and pasted into documents. Documentation files, such as codebooks and questionnaires, can be downloaded and viewed online.
As of 2024, some 32.6 percent of U.S. youths aged 12 to 17 years with a major depressive episode within the past year also used an illicit drug in the past year. This statistic depicts the percentage of youth in the United States with substance use as of 2024, sorted by major depressive episode.
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2007 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. Background information includes sex, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. This study has 1 Data Set.
From 2018 to 2019, around 3.2 percent of adolescents aged 12 to 17 years in the United States reported having an illicit drug use disorder during the past year. This statistic illustrates the percentage of adolescents in the U.S. with substance use disorders from 2018 to 2019.
https://www.icpsr.umich.edu/web/ICPSR/studies/4373/termshttps://www.icpsr.umich.edu/web/ICPSR/studies/4373/terms
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2004 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and retained through the 2003 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. In addition, in 2004 Adult and Adolescent Mental Health modules were added.
This survey shows the percentage of adolescents in Texas aged 12 to 17 years who used illicit drugs in the past month from 2010 to 2014. In 2013-2014 approximately *** percent of teenagers in Texas used illicit drugs in the past month, slightly lower from the national average of *** percent.
The goal of the Arrestee Drug Abuse Monitoring (ADAM) Program is to determine the extent and correlates of illicit drug use in the population of booked arrestees in local areas. Data were collected in 2001 at four separate times (quarterly) during the year in 33 metropolitan areas in the United States. The ADAM program adopted a new instrument in 2000 in adult booking facilities for male (Part 1) and female (Part 2) arrestees. Data from arrestees in juvenile detention facilities (Part 3) continued to use the juvenile instrument from previous years, extending back through the DRUG USE FORECASTING series (ICPSR 9477). The ADAM program in 2001 also continued the use of probability-based sampling for male arrestees in adult facilities, which was initiated in 2000. Therefore, the male adult sample includes weights, generated through post-sampling stratification of the data. For the adult files, variables fell into one of eight categories: (1) demographic data on each arrestee, (2) ADAM facesheet (records-based) data, (3) data on disposition of the case, including accession to a verbal consent script, (4) calendar of admissions to substance abuse and mental health treatment programs, (5) data on alcohol and drug use, abuse, and dependence (6) drug acquisition data covering the five most commonly used illicit drugs, (7) urine test results, and (8) weights. The juvenile file contains demographic variables and arrestee's self-reported past and continued use of 15 drugs, as well as other drug-related behaviors.
https://www.icpsr.umich.edu/web/ICPSR/studies/23782/termshttps://www.icpsr.umich.edu/web/ICPSR/studies/23782/terms
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2007 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
This report uses 2002 to 2010 National Survey on Drug Use and Health (NSDUH) to assess the average number of adolescents aged 12 to 17 using substances for the first time per day for the year as a whole and for each month of the year. Substances examined include alcohol, cigarettes, cigars, marijuana, nonmedical use of prescription type drugs, inhalants, hallucinogens, and cocaine. Results are shown for each substance by month.
Find data on the nonuse of substances among adolescents aged 12 to 17 from the 2023 National Survey on Drug Use and Health (NSDUH). Estimates include illicit drugs, alcohol, tobacco products, and nicotine vaping.
https://www.icpsr.umich.edu/web/ICPSR/studies/37025/termshttps://www.icpsr.umich.edu/web/ICPSR/studies/37025/terms
The National Survey of Youth in Custody (NSYC) is part of the BJS National Prison Rape Statistics Program to gather mandated data on the incidence of prevalence of sexual assault in juvenile facilities under the Prison Rape Elimination Act of 2003 (PREA; P.L. 108-79). The Act requires a 10 percent sample of juvenile facilities to be listed by incidence of sexual assault. Data are collected directly from youth in a private setting using audio computer-assisted self interview (ACASI) technology with a touch-screen laptop and an audio feed to maximize inmate confidentiality and minimize literacy issues. The first year of collection includes nearly 200 juvenile facilities, with an estimated 10,000 completed interviews with youth. The National Survey of Youth in Custody Alternate (NSYC-A) is a supplement to NSYC that collected information on drug and alcohol use by youth in juvenile facilities. The survey was divided into six sections. Section A collected background information, such as age, gender, education level, and whether respondent had stayed overnight in a facility or had forced sexual contact prior to current incarceration. Section B, Facility Perceptions and Victimization, is not included in this dataset. Section C, Drug Use, included whether the respondent had ever used specific types of drugs, frequency of use in the past and immediately before being taken into custody, source of drugs, and symptoms of drug abuse and dependence. Section D, Alcohol Use, captured alcohol dependence and abuse symptoms. Section E, Treatment, focused on drug or alcohol treatment programs respondent had attended prior to being taken into custody. Section F, Family and Peer Background is not included in this dataset. Other items include weights variables and derived variables regarding DSM IV drug dependence symptoms, alcohol and drug use/dependence/abuse status, outliers/illogical responses, and categorized demographic variables.
Around 25 percent of U.S. respondents in grades 8, 10, and 12 in 2024 stated that they used any illicit drug within their lifetime. This survey shows the lifetime prevalence of use of any illicit drug for grades 8, 10, and 12 combined from 1991 to 2024.